A majority of patients with advanced lung and colorectal cancer harbor the fundamental misperception that treatments that can extend life and alleviate pain might also cure them, according to a new study led by Dana-Farber Cancer Institute researchers.

The finding highlights a breakdown in the difficult and important conversations physicians have with patients about their prognosis, say the authors.